About Tripartite motif-containing protein 14
Tripartite motif-containing protein 14 (TRIM14) is a protein
from Homo sapiens identified by UniProt accession
Q14142, 442 residues long.
MolForge cross-references it against 0 known binders and
108 disease associations.
Target properties
| Protein name | Tripartite motif-containing protein 14 |
| UniProt accession | Q14142 |
| Gene | TRIM14 |
| Organism | Homo sapiens |
| Length | 442 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (108)
Diseases linked to this target (Open Targets).
- spondyloepimetaphyseal dysplasia, Genevieve type · score 0.53
- multiple sclerosis · score 0.29
- genetic disorder · score 0.19
- reticulocyte count · score 0.13
- eosinophil count · score 0.11
- neoplasm · score 0.10
- hepatocellular carcinoma · score 0.09
- breast cancer · score 0.08
- gonorrhea · score 0.08
- non-small cell lung carcinoma · score 0.08
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14142-F1 | alphafold | PREDICTED | 85.72 | — |
Amino-acid sequence (442 residues)
MAGAATGSRT PGRSELVEGC GWRCPEHGDR VAELFCRRCR RCVCALCPVL GAHRGHPVGL ALEAAVHVQK LSQECLKQLA IKKQQHIDNI TQIEDATEKL KANAESSKTW LKGKFTELRL LLDEEEALAK KFIDKNTQLT LQVYREQADS CREQLDIMND LSNRVWSISQ EPDPVQRLQA YTATEQEMQQ QMSLGELCHP VPLSFEPVKS FFKGLVEAVE STLQTPLDIR LKESINCQLS DPSSTKPGTL LKTSPSPERS LLLKYARTPT LDPDTMHARL RLSADRLTVR CGLLGSLGPV PVLRFDALWQ VLARDCFATG RHYWEVDVQE AGAGWWVGAA YASLRRRGAS AAARLGCNRQ SWCLKRYDLE YWAFHDGQRS RLRPRDDLDR LGVFLDYEAG VLAFYDVTGG MSHLHTFRAT FQEPLYPALR LWEGAISIPR LP
Explore Tripartite motif-containing protein 14 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets